MEN’S HEALTH MONDAY
 
Panel crafts recommendations for cath management following BPH surgery
An expert multidisciplinary panel using robust methodology has developed recommendations for guiding urinary catheter management after transurethral surgery for BPH.
Learn more
ADVERTISEMENT
 
Video: How will PARP inhibitors change advanced PCa treatment?
Maha H. Hussain, MD, discusses the impact of PARP inhibitors on the management of advanced prostate cancer.
Watch the video
 
ASCO publishes prostate cancer biomarker guideline
“To my knowledge, this is the first sanctioned guideline from a national organization that addresses the role of molecular biomarker testing for localized prostate cancer,” says guideline panel co-chair Scott E. Eggener, MD.
What you should know
ADVERTISEMENT
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
ADVERTISEMENT
Real-world data on the prostate cancer "revolution"
This Partner Perspective examines and reviews key insights from the PROCEED registry, a multicenter, open-label, observational registry of nearly 2,000 men with mCRPC. Read now.
 
 
MORE FROM UROLOGY TIMES
 
Risk of chronic opioid use low after RP
Prostate ablation technique yields positive results at 1 year
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont